Last reviewed · How we verify

NCT05388851

Education for Prevention of Melanoma in Hispanic Populations

Terminated Phase 2 Last updated 22 June 2025
What this trial tests

Phase 2 trial testing Educational Intervention in Melanoma in 145 participants. Terminated before completion.

Timeline
12 January 2022
Primary endpoint
13 September 2022
13 September 2022

Quick facts

Lead sponsorMayo Clinic
PhasePhase 2
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment145
Start date12 January 2022
Primary completion13 September 2022
Estimated completion13 September 2022
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Melanoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is to develop an educational platform to educate and prevent melanoma in Hispanic populations. Melanoma is cancer arising in the skin. Educational platforms to increase the knowledge and practice of sun smart behaviors (sunscreen use, sun protective clothing use, self-skin examination) may help reduce risk of and incidence of melanoma and improve cancer survival.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Educational Intervention

Trials testing the same drug.

Other recruiting trials for Melanoma

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05388851.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing